Abu Dhabi Signs Landmark MoU with ADIO, Etihad Airways, and AD Ports Group to Become Global Pharma and Life Sciences Hub

BIO International Convention 2024, The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, and Abu Dhabi...

June 10, 2024 | Monday | News
Asensus Surgical to be Acquired by KARL STORZ in $300 Million Deal

Asensus Surgical, , a global leader of innovative digital solutions for the operating room, today announced that it has entered into a definitive merger ...

June 10, 2024 | Monday | News
FDA Accepts Eisai and Biogen’s Application for Monthly Maintenance Dosing of Alzheimer's Drug LEQEMBI

Eisai Co.,  and Biogen announced that the U.S. Food and Drug Administration (FDA) has accepted Eisai’s Supplemental Biologics License Applicat...

June 10, 2024 | Monday | News
Vetter Announces Expansion Plans to Boost Capacity in the U.S. and Germany

  Vetter Advisory Board decides on strategic path forward for further independent and sustainable growth    Des Plaines, IL, and Saa...

June 07, 2024 | Friday | News
South Korean Firm MediMab Biotherapeutics Opens New CL2 Wet Lab at Abingdon Science Park

New CL2 wet lab purpose-built facilities delivered by Kadans Science Partner will support MediMab Biotherapeutics to identify first-in-class immuno-oncol...

June 06, 2024 | Thursday | News
Ecolab and Repligen Unveil Groundbreaking Protein A Chromatography Resin at BIO 2024

Ecolab announced that its Purolite resin business, together with Repligen Corporation, a life sciences company focused on bioprocessing technology leader...

June 04, 2024 | Tuesday | News
BIO 2024: U.S. Officials Emphasize Vital National Security Partnership with Biotech Industry

At the opening of the 2024 BIO International Convention in San Diego, federal officials underscored the critical role of the biotechnology industry in sa...

June 04, 2024 | Tuesday | News
Gerresheimer Invests $180 Million to Expand Medical Systems Production in the U.S., Creating Over 400 New Jobs

Gerresheimer, an innovative systems and solutions provider and global partner for the pharma, biotech and cosmetics industries, is significantly expandin...

May 28, 2024 | Tuesday | News
Roche’s Inavolisib Receives Breakthrough Designation for Advanced Breast Cancer Treatment

The designation is based on Phase III INAVO120 results, showing the inavolisib-based regimen more than doubled progression-free survival compared with pa...

May 21, 2024 | Tuesday | News
Sanofi, Formation Bio, and OpenAI Forge Pioneering Partnership to Transform Drug Development with AI

Sanofi, Formation Bio and OpenAI are collaborating to build AI-powered software to accelerate drug development and bring new medicines to patients more eff...

May 21, 2024 | Tuesday | News
Genentech Reports Positive Phase Ib Results for Its Dual GLP-1/GIP Receptor Agonist CT-388 in People With Obesity

Genentech, a member of the Roche Group  announced positive results from the Phase Ib clinical trial of CT-388, a dual GLP-1/GIP receptor agonist being...

May 16, 2024 | Thursday | News
OmniAb, Inc. Showcases Breakthrough in Antibody Discovery at PEGS Boston Summit

OmniAb, Inc. announced its participation in the 20th Annual PEGS Boston – The Essential Protein & Antibody Engineering Summit underway at the Omn...

May 16, 2024 | Thursday | News
Atraverse Medical's HOTWIRE™ RF Guidewire Receives FDA Clearance, Revolutionizing Left-Heart Access

Atraverse Medical, a San Diego-based medical device company, announces the FDA clearance of its HOTWIRE™ radiofrequency (RF) guidewire, a novel devic...

May 15, 2024 | Wednesday | News
Moderna's Investigational RSV Vaccine Review Delayed by FDA

Moderna, Inc. received notification from the U.S. Food and Drug Administration (FDA) regarding a delay in the review process for its investigational respir...

May 13, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close